CommercialPrior AuthHigh impact
Positive Pressure Ventilation (CPB 0452, reviewed 2026-07-01)
Aetna·Pulmonology, Sleep Medicine, Critical Care +3 more·Medical Policy
Effective date
Jul 1, 2026
We identified it
Aug 13, 2026
Summary
Aetna has updated its Positive Pressure Ventilation policy (CPB 0452, effective July 1, 2026) establishing comprehensive medical necessity criteria for noninvasive positive pressure ventilation (NPPV) devices including bilevel PAP with and without backup rate features. The policy specifies detailed diagnostic testing requirements, clinical thresholds (e.g., PaCO2 levels, oxygen saturation parameters), and conditions under which each device type is covered for restrictive thoracic disorders, COPD, sleep apnea, hypoventilation syndrome, and other respiratory conditions. Billing teams must implement prior authorization workflows requiring documented arterial blood gas values, sleep studies, spirometry results, and compliance monitoring to support claims.
Action Required
By July 1, 2026: Billing and authorization teams must implement the following: (1) Create prior authorization requirements in billing system for CPT codes related to NPPV and bilevel PAP devices, requiring submission of: arterial blood gas results (PaCO2 and FIO2 documented), sleep oximetry or polysomnography results showing oxygen saturation thresholds, spirometry (FEV1/FVC ratio), and diagnosis-specific criteria documentation; (2) For COPD claims, require providers to document that OSA has been ruled out before authorization; (3) For COPD bilevel PAP WITH backup rate, require documentation of either (a) facility-based PSG during bilevel PAP use showing continued desaturation, OR (b) 60+ days of compliant use (4 hours/day average) with worsening PaCO2; (4) For restrictive thoracic/neuromuscular disease, require proof of progressive disease and sleep-associated hypoventilation symptoms; (5) For CSA/CompSA, require complete attended inpatient polysomnogram documenting improvement with prescribed bilevel PAP settings; (6) For hypoventilation syndrome, verify FEV1/FVC ≥70% and document PaCO2 worsening ≥7 mm Hg; (7) Track and require re-evaluation documentation after 2-3 months showing compliant use (4 hours/24-hour average) and clinical benefit for continued coverage beyond 3 months; (8) Update claim submission templates and provider education materials to include all required clinical parameters. Providers must submit complete documentation or claims will be denied. Billing team responsible for system configuration; Providers responsible for documentation submission.